Effect of Pneumatic Intermittent Venous Compression on Fluid Volumes Infused During Major Abdominal Surgery
- Conditions
- Major Abdominal Surgery
- Interventions
- Device: Intermittent pneumatic compressionProcedure: Standard care
- Registration Number
- NCT01403909
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Brief Summary
The main objective of this study was to evaluate the effect of intermittent pneumatic venous compression on intra-operative fluid intake by comparing two groups of patients with or without intermittent pneumatic compression of the lower limbs.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- The patient must have given his/her informed and signed consent
- The patient must be insured or beneficiary of a health insurance plan
- Patient with ASA score 1-3
- Body mass index < 30 kg/m^2
- Patient is schelduled for major abdominal surgery (laparotomy without risk of haemorrhage whose duration is assumed to be greater than 120 min)
- The patient passes from home, directly to the hospital, without schelduled hospitalization in another department
- The patient is participating in another study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient refuses to sign the consent
- It is impossible to correctly inform the patient
- The patient is pregnant
- The patient is breastfeeding
- The patient has a contra-indication for treatment necessary for the study
- ASA score > 3
- body mass index > 30 kg/m^2
- Expected surgical time of < 120 minutes
- Surgery with risk of hemorrhage
- Surgery via celioscopy
- The surgery require perineal access, thus rendering any blinding impossible
- Hepatic surgery
- Contra indication for intermittent venous compression
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description With compression Intermittent pneumatic compression The patients randomized to this group will have intermittent pneumatic venous compression of the lower limbs during surgery. Without compression Standard care The patients randomized to this group will not have intermittent pneumatic venous compression of the lower limbs during surgery. (Standard care)
- Primary Outcome Measures
Name Time Method Volume fluids (ml) End of surgery (expected mean of 2 hours) The total volume of infused fluids (Ringer's Lactate and HES) delivered to the patient during surgery (ml)
- Secondary Outcome Measures
Name Time Method Hypotensive episodes end of surgery (expected mean of 2 hours) The number of arterial hypotension episodes (systolic pressure \< 90 mmHg)
VEGF end of surgery (expected mean of 2 hours) Concentration (pg/ml) of Vascular Endothelial Growth Factor (VEGF) in blood
sFlt1 end of surgery (expected mean of 2 hours) Concentration (pg/ml) of soluble vascular endothelial growth factor receptor-1 (sFlt1) in blood
Albumin end of surgery (expected mean of 2 hours) Albuminemia (g/l)
Days of hospitalization 28 days Length of hospitalization (days)
Hematocrit % end of surgery (expected mean of 2 hours) Presence/absence of POSSUM complications 28 days Presence/absence of complications as defined by the Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity (POSSUM) criteria
Number of days not in hospital 28 days Number of days not in hospital
Prothrombin (%) end of surgery (expected mean of 2 hours) Prothrombin rate in blood
Activated partial thromboplastin time end of surgery (expected mean of 2 hours) Activated partial thromboplastin time (seconds)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Centre Hospitalier Universitaire de Nîmes
🇫🇷Nîmes Cedex 09, Gard, France